Active, not recruitingNCT04177394

MitraClip EXPAND G4 Study

Abbott Medical DevicesMultiple US sitesView on ClinicalTrials.gov

AI Description

This primary objective of the EXPAND G4 study is to confirm the safety and performance of the MitraClip G4 System in a post-market setting.

Report inaccurate information

Who can join
child, adult, older adult
Participants
1164
Expected completion
2028-03
Funded by
industry

Conditions studied

Mitral Regurgitation, Mitral Valve Regurgitation

What is being tested

  • DEVICE: MitraClip G4 System

What it measures

  • Number of Participants With Mitral Valve Regurgitation Severity ≤2+ at 30 Days, Mitral Valve Regurgitation (MR) Severity of 2+ or less at 30 days, At 30 days
  • Occurrence of Major Adverse Events (MAE) at 30 Days, MAE is defined as a composite of all-cause Death, Myocardial Infarction, Stroke, or non-elective Cardiovascular (CV) surgery for device related complications., At 30 days

Working with

Abbott

Centers Participating

These centers are participating in this study. Reach out to them directly to learn more.

Data Sources and Methodology

Registry entry updated 2025-07-11

Deciding whether to join a study is your choice, and you can ask a study team questions before you decide anything.

If you would rather we did it with you, call us on (656) 206-4686.